Accelerating global access to life-saving vaccines.

We apply rigorous science to build knowledge and support for the value of vaccines.

Watch Webinar: Addressing challenges in vaccination in fragile contexts
May 2021

Description: With COVID-19 vaccines now available worldwide, reaching underserved and vulnerable populations is a priority under the Immunization Agenda 2030 (IA2030). Numerous challenges and operational issues have presented themselves in fragile contexts including vaccine access, risk of vaccine preventable diseases, and vaccine hesitancy. The IA2030 Strategic Priority 5 working group discussed vaccinating against COVID-19 in fragile contexts in coordination […]

Read More >
Investments in Disease Surveillance Support Kenya’s Response to COVID-19
May 2021

With the enormous strain COVID-19 is placing on health systems, disease surveillance has been challenging but ever more essential. Countries needed to continue monitoring for vaccine-preventable diseases while also launching new surveillance activities for COVID-19. Kenya, which has fortunately seen lower COVID-19 case counts to date than other African countries, got a running start on […]

Read More >
Digital Tools

IVAC’s digital platforms contain downloadable vaccine introduction maps, messaging compendiums, advocacy guides, and more.

Where We Work

IVAC works with governments and major research institutions in 38 countries

[Where We Work - Map]